ALpHA G Capsule Filter for Single-Use Systems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ALpHA G Capsule Filter for Single-Use Systems


Pharmaceutical Technology
Volume 38, Issue 1, pp. 16
The ALpHA G is an absolute rated depth type prefilter, which has been optimized for compatibility with a gamma irradiation cycle commonly used to sterilize single-use systems. ALpHA G features a tapered pore structure, which provides high flow rates and delivers increased dirt holding capacity. ALpHA G capsule filters are available in retention ratings from 0.6 μm to 20 μm. The filter can be specified in a wide range of capsule configurations to provide seamless scalability from laboratory work and process development through production. For applications requiring multistage filtration and larger surface areas than can be accommodated by a single filter, the ALpHA G media can be specified in the UltraSnap filter assembly. The UltraSnap assembly can be delivered as a single presterilized unit with one inlet and one outlet for maximum convenience and plug and play functionality.

Meissner

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here